Home / Ranitidine / Canada
CA ATC A02BA02 · updated 2 Nov 2026
Ranitidine shortage in Canada
Is there a Ranitidine shortage in Canada?
Yes. As of 2 Nov 2026, 16 Ranitidine products are reported short in Canada, the first since 10 Mar 2017. No return date has been given. Main reason: manufacturing problem.
Not reported short in any other country we track. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | ACID REDUCER (6/10 BLS) | APOTEX INC | 10 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | RIVA-RANITIDINE 150 (60) | LABORATOIRE RIVA INC | 13 Sep 2019 | not given | Other Other (Please describe in comments) |
| CA | RIVA-RANITIDINE 300 (30 & 100) | LABORATOIRE RIVA INC | 13 Sep 2019 | not given | Other Other (Please describe in comments) |
| CA | RANITIDINE (100) | SANIS HEALTH INC | 16 Sep 2019 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | RANITIDINE (500) | SANIS HEALTH INC | 16 Sep 2019 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | APO-RANITIDINE (300 ML) | APOTEX INC | 17 Sep 2019 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-RANITIDINE TABLET 150MG (500 BTL) | APOTEX INC | 17 Sep 2019 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-RANITIDINE TABLET 300MG (100 BTL) | APOTEX INC | 17 Sep 2019 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-RANITIDINE (100) | JAMP PHARMA CORPORATION | 7 Oct 2019 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-RANITIDINE (100) | JAMP PHARMA CORPORATION | 7 Oct 2019 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-RANITIDINE (500) | JAMP PHARMA CORPORATION | 7 Oct 2019 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PMS-RANITIDINE 150 MG (100) | PHARMASCIENCE INC | 23 Oct 2019 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PMS-RANITIDINE 150 MG (500) | PHARMASCIENCE INC | 23 Oct 2019 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PMS-RANITIDINE 150 MG (60) | PHARMASCIENCE INC | 23 Oct 2019 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PMS-RANITIDINE 300 MG (100) | PHARMASCIENCE INC | 23 Oct 2019 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-RANITIDINE TABLET 300MG (500 BTL) discontinuation | APOTEX INC | not given | not given | Not stated |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.